abstract
acts
autoimmune
cannabinoid
case
cb2
cb2r
diseases
drugs
due
era
heterogeneous
immune
itp
k2
literature
marijuana
mimetics
pathogenesis
polymorphisms
prednisolone
presented
receptors
secondary
successfully
synthetic
thrombocytes
thrombocytopenia
usage
|